LGC Biosearch Technologies A/S
CVR 34884900 · Public limited company (A/S) · Active · Low risk
LGC Biosearch Technologies A/S is a Public limited company (A/S), founded on , based in Lystrup. The company is registered in the industry fremstilling af andre kemiske produkter i.a.n.. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 13 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Mar 2026) shows equity of DKK 88.1m and a net result of DKK 8.2m. CEO: Daren Dick.
Bankruptcy risk for LGC Biosearch Technologies A/S
0.0 × the average (1.41%) · higher risk than 6% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 34884900
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (13 years)
- Address
- Sønderskovvej 5
8520 Lystrup - Municipality
- Aarhus
- Industry
- Fremstilling af andre kemiske produkter i.a.n. (205900)
Bankruptcies in the industry: Fremstilling af parfume, hårshampoo, tandpasta mv. - Share capital
- DKK 500k
- Employees
- 21 (2018)
- Auditor
- KPMG P/S
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 13 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 92.1% |
| Current ratio | 895% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 2 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Revenue | DKK 106.7m | DKK 114.5m | DKK 105.6m |
| Gross profit | DKK 53.4m | DKK 58.9m | DKK 46.3m |
| Net profit | DKK 8.2m | DKK 11.8m | DKK 2.6m |
| Equity | DKK 88.1m | DKK 91.7m | DKK 79.9m |
| Total assets | DKK 95.6m | DKK 111.0m | DKK 99.6m |
| Cash | DKK 27.4m | DKK 32.1m | – |
| Short-term debt | DKK 7.5m | DKK 18.2m | – |
| Tax owed | DKK 81k | DKK 632k | – |
| Avg. employees | 46 | 51 | – |
Latest annual report: Reporting class C, mellemstor virksomhed · auditor's statement: Independent Auditor’s Report · KPMG Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Apr 2025 – 31 Mar 2026 | 184 | Late | |
| 1 Apr 2024 – 31 Mar 2025 | 178 | ||
| 1 Apr 2023 – 31 Mar 2024 | 194 | Late | |
| 1 Apr 2022 – 31 Mar 2023 | 98 | ||
| 1 Apr 2021 – 31 Mar 2022 | 179 | ||
| 1 Apr 2020 – 31 Mar 2021 | 134 | ||
| 1 Apr 2019 – 31 Mar 2020 | 147 | ||
| 1 Apr 2018 – 31 Mar 2019 | 145 | ||
| 1 Apr 2017 – 31 Mar 2018 | 159 | ||
| 1 Apr 2016 – 31 Mar 2017 | 167 | ||
| 1 Jan 2015 – 31 Mar 2016 | 130 | ||
| 1 Jan 2014 – 31 Dec 2014 | 107 | ||
| 1 Dec 2012 – 31 Dec 2013 | 142 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Daren Dick | Current | |
| Board | Henrik Daugård | Current | |
| Board | Bettina Kecskes | Current | |
| Board | Daren Dick | Current | |
| Board | Peter Jay Coassin | ||
| Board | Joanne Ellen Giffra | ||
| Board | Ronald Michael Cook | ||
| Board | Simon Lawrence Parsons | ||
| Board | Timothy Michael Robinson | ||
| Board | Giulio Cerroni | ||
| Board | Ross Frazer Finlay | ||
| Board | Anders Hougaard Ager | ||
| Board | Jakob Thielke Karaffa | ||
| Board | Lucas-Caspar Schwinner-Strachwitz | ||
| Owner (100%) | Biosearch Technologies, Inc. | Current | |
| Auditor | KPMG P/S | Current | |
| Auditor | Datoselskabet af den 3. juli 2016 RVT P/S | ||
| Auditor | Datoselskabet af den 3. juli 2016 RVT P/S | ||
| Auditor | EY Godkendt Revisionspartnerselskab | ||
| Founder | Ronald Michael Cook | Current |
Address history (3 moves)
| Sønderskovvej 5, 8520 Lystrup | |
| Sønderskovvej 5, 8520 Lystrup | |
| Voldbjergvej 16, 1. th, 8240 Risskov | |
| Voldbjergvej 16B, 8240 Risskov |
Former names
| LGC Biosearch Technologies A/S | – now |
| DNA TECHNOLOGY A/S | – |
| BIOSEARCH TECHNOLOGIES DENMARK A/S | – |
Employees per year
Other companies at the same address
- MOGRAFO A/S Opløst
- PP A/S Opløst
Similar companies in Aarhus
- DNA DIAGNOSTIC A/S Risskov
- NorFalk A/S Risskov
- NorFalk Holding ApS Risskov
- DuPont de Nemours Denmark ApS Brabrand
- Aarhus Protein A/S Aarhus C
- DRIFTSLABORATORIET ApS Højbjerg
- KULTUR Holding ApS Risskov
- Kilco Danmark ApS Aarhus C
- MoleCure IVS Aarhus C
- CELLCURE A/S Århus C
- X-COATING ApS Århus C
Questions and answers about LGC Biosearch Technologies A/S
Has LGC Biosearch Technologies A/S gone bankrupt?
No, LGC Biosearch Technologies A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of LGC Biosearch Technologies A/S?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of LGC Biosearch Technologies A/S?
Daren Dick is the CEO of LGC Biosearch Technologies A/S.
Who is the auditor of LGC Biosearch Technologies A/S?
LGC Biosearch Technologies A/S most recently used KPMG P/S.
When was LGC Biosearch Technologies A/S founded?
LGC Biosearch Technologies A/S was founded on 1 December 2012.
What is the equity of LGC Biosearch Technologies A/S?
Equity was DKK 88.1m according to the annual report for the period ending 31 March 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.